| ATP-dependent citrate lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling of the Heart S Liu, ST Gammon, L Tan, Y Gao, K Kim, IK Williamson, J Pham, ... bioRxiv, 2024.06. 21.600099, 2024 | | 2024 |
| Comparison between experimental glaucoma (EG) and axotomy on segmented retinal layer thickness using optical coherence tomography (OCT) in macaques T Lavery, C Rasmussen, A Katz, CBY Kim, JN Ver Hoeve, ... Investigative Ophthalmology & Visual Science 65 (7), 6759-6759, 2024 | | 2024 |
| Dimerization of the 4Ig isoform of B7-H3 in tumor cells mediates enhanced proliferation and tumorigenic signaling MN Sutton, SE Glazer, R Muzzioli, P Yang, ST Gammon, ... Communications Biology 7 (1), 21, 2024 | 1 | 2024 |
| Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration A Liu, ST Gammon, F Pisaneschi, A Boda, CR Ager, D Piwnica-Worms, ... JCI insight 9 (1), 2024 | 1 | 2024 |
| Hypoxia-activated prodrug and anti-angiogenic therapy cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration A Liu, ST Gammon, F Pisaneschi, A Boda, CR Ager, D Piwnica-Worms, ... JCI Insight, 2023 | | 2023 |
| ATP-Dependent Citrate Lyase Drives Cardiac Left Ventricular Dysfunction by Metabolic Remodeling S Liu, K Kim, Y Gao, S Gammon, L Tan, H Taegtmeyer, P Lorenzi, ... Circulation 148 (Suppl_1), A19008-A19008, 2023 | | 2023 |
| Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Radioligand Therapy Applications R Muzzioli, F Pisaneschi, S Gammon, M Sutton, A Napoli, L McIntosh, ... Nuclear Medicine and Biology 126, 108432, 2023 | | 2023 |
| cGMP synthesis of 4-[18F] fluoro-1-naphthol, a novel PET tracer for imaging activation of innate immunity F Pisaneschi, V Paolillo, R Ta, M Lin, C Manning, S Gammon, ... Nuclear Medicine and Biology 126, 108467, 2023 | | 2023 |
| Gender Differences in a Mouse Model of Hepatocellular Carcinoma Revealed Using Multi-Modal Imaging BJ Engel, V Paolillo, MN Uddin, KA Gonzales, KM McGinnis, MN Sutton, ... Cancers 15 (15), 3787, 2023 | | 2023 |
| A novel high affinity anti-B7H3 antibody selective for the 4Ig-B7H3 isoform when labeled with ytrrium-90 provides long term survivors for established radioresistant colorectal … S Glazer, M Sutton, P Yang, F Pisaneschi, S Gammon, D Piwnica-Worms Journal of Nuclear Medicine 64 (supplement 1), P1021-P1021, 2023 | | 2023 |
| Co-clinical imaging metadata information (CIMI) for cancer research to promote open science, standardization, and reproducibility in preclinical imaging SM Moore, JD Quirk, AW Lassiter, R Laforest, GD Ayers, CT Badea, ... Tomography 9 (3), 995-1009, 2023 | 3 | 2023 |
| Evaluation of 89Zr-Labeled Anti-PD-L1 Monoclonal Antibodies Using DFO and Novel HOPO Analogues as Chelating Agents for Immuno-PET B Radaram, SE Glazer, P Yang, CW Li, MC Hung, ST Gammon, ... ACS omega 8 (19), 17181-17194, 2023 | 1 | 2023 |
| Single dose treatment with a novel Yttrium-90-labeled high affinity anti-B7-H3 antibody selective for the 4Ig-B7-H3 isoform provides long term survivors for established … S Glazer, M Sutton, P Yang, F Pisaneschi, S Gammon, D Piwnica-Worms Cancer Research 83 (7_Supplement), 5036-5036, 2023 | 1 | 2023 |
| Statins inhibit onco-dimerization of 4Ig-B7-H3 MN Sutton, SE Glazer, R Muzzioli, P Yang, ST Gammon, ... Cancer Research 83 (7_Supplement), 6416-6416, 2023 | | 2023 |
| An online repository for pre-clinical imaging protocols (PIPs) ST Gammon, AS Cohen, AL Lehnert, DC Sullivan, D Malyarenko, ... Tomography 9 (2), 750-758, 2023 | 3 | 2023 |
| Evaluation of apparent diffusion coefficient repeatability and reproducibility for preclinical MRIs using standardized procedures and a diffusion-weighted imaging phantom D Malyarenko, G Amouzandeh, S Pickup, R Zhou, HC Manning, ... Tomography 9 (1), 375-386, 2023 | 3 | 2023 |
| Tumor-associated nonmyelinating Schwann cell–expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion C Sun, Y Ye, Z Tan, Y Liu, Y Li, W Hu, K Liang, SD Egranov, LA Huang, ... Science Advances 9 (5), eadd6995, 2023 | 15 | 2023 |
| Combination therapies for the treatment of cancer D Piwnica-Worms, C Gonzalez, S Gammon US Patent App. 17/782,147, 2023 | | 2023 |
| Anti-b7-h3 monoclonal antibody and methods of use thereof D Piwnica-Worms, S Gammon, F Pisaneschi US Patent App. 17/777,946, 2023 | | 2023 |
| TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy C Gonzalez, S Williamson, ST Gammon, S Glazer, JH Rhee, ... Communications Biology 6 (1), 31, 2023 | 11 | 2023 |
